FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Janet Lathey

Research Profile

Living Beings

Disorders

Chemicals & Drugs

Procedures

CD4 Lymphocyte Count

Physiology

Virus Replication

Anatomy

Concepts & Ideas

Co-author Network

Publications

TOP 3
Patricia M Flynn; Bret J Rudy; Jane C Lindsey; Steven D Douglas; Janet L Lathey; Stephen A Spector; Jaime Martinez; Margarita Silio; Marvin Belzer; Lawrence B Friedman; Lawrence D'Angelo; Elizabeth Smith; Janice Hodge; Michael D Hughes
Long-term observation of adolescents initiating HAART therapy: three-year follow-up.
Patricia M Flynn; Bret J Rudy; Steven D Douglas; Janet L Lathey; Stephen A Spector; Jaime Martinez; Margarita Silio; Marvin Belzer; Lawrence B Friedman; Lawrence D'Angelo; James McNamara; Janice Hodge; Michael D Hughes; Jane C Lindsey
Virologic and immunologic outcomes after 24 weeks in HIV type 1-infected adolescents receiving highly active antiretroviral therapy.
Hulin Wu; Janet L Lathey; Ping Ruan; Steven D Douglas; Stephen A Spector; Jane Lindsey; Michael D Hughes; Bret J Rudy; Patricia M Flynn
Relationship of plasma HIV-1 RNA dynamics to baseline factors and virological responses to highly active antiretroviral therapy in adolescents (aged 12-22 years) infected through high-risk behavior.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Janet Lathey (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2007: Patricia M Flynn; Bret J Rudy; Jane C Lindsey; Steven D Douglas; Janet L Lathey; Stephen A Spector; Jaime Martinez; Margarita Silio; Marvin Belzer; Lawrence B Friedman; Lawrence D'Angelo; Elizabeth Smith; Janice Hodge; Michael D Hughes
Long-term observation of adolescents initiating HAART therapy: three-year follow-up.
AIDS research and human retroviruses 2007;23(10):1208-14.
2004: Patricia M Flynn; Bret J Rudy; Steven D Douglas; Janet L Lathey; Stephen A Spector; Jaime Martinez; Margarita Silio; Marvin Belzer; Lawrence B Friedman; Lawrence D'Angelo; James McNamara; Janice Hodge; Michael D Hughes; Jane C Lindsey
Virologic and immunologic outcomes after 24 weeks in HIV type 1-infected adolescents receiving highly active antiretroviral therapy.
The Journal of infectious diseases 2004;190(2):271-9.
2004: Hulin Wu; Janet L Lathey; Ping Ruan; Steven D Douglas; Stephen A Spector; Jane Lindsey; Michael D Hughes; Bret J Rudy; Patricia M Flynn
Relationship of plasma HIV-1 RNA dynamics to baseline factors and virological responses to highly active antiretroviral therapy in adolescents (aged 12-22 years) infected through high-risk behavior.
The Journal of infectious diseases 2004;189(4):593-601.
2003: Camlin Tierney; Janet L Lathey; Cindy Christopherson; Daniel M Bettendorf; Richard T D'Aquila; Scott M Hammer; David A Katzenstein
Prognostic value of baseline human immunodeficiency virus type 1 DNA measurement for disease progression in patients receiving nucleoside therapy.
The Journal of infectious diseases 2003;187(1):144-8.
2002: Barbara Klencke; Mark Matijevic; Robert G Urban; Janet L Lathey; Mary Lynne Hedley; Michael Berry; Joe Thatcher; Vivian Weinberg; Jennifer Wilson; Teresa M Darragh; Naomi Jay; Maria Da Costa; Joel Palefsky
Encapsulated plasmid DNA treatment for human papillomavirus 16-associated anal dysplasia: a Phase I study of ZYC101.
Clinical cancer research : an official journal of the American Association for Cancer Research 2002;8(5):1028-37.
2002: Samuel Song; Joseph Goodwin; Jenny Zhang; Bruce Babbitt; Janet L Lathey
Effect of contaminating red blood cells on OKT3-mediated polyclonal activation of peripheral blood mononuclear cells.
Clinical and diagnostic laboratory immunology 2002;9(3):708-12.
2002: John L Schmitz; Thomas N Denny; Ambrosia Garcia; Janet L Lathey
Comparison of human immunodeficiency virus antigens as stimulants for lymphocyte proliferation assays.
Clinical and diagnostic laboratory immunology 2002;9(3):525-9.
2001: Janet L Lathey; Camlin Tierney; S Y Chang; Richard T D'Aquila; D M Bettendorf; H C Alexander; C D Santini; A M Hughes; Charlene F Barroga; Stephen A Spector; J E Landes; Scott M Hammer; David A Katzenstein
Associations of CCR5, CCR2, and stromal cell-derived factor 1 genotypes with human immunodeficiency virus disease progression in patients receiving nucleoside therapy.
The Journal of infectious diseases 2001;184(11):1402-11.
2000: Janet L Lathey; Donald J Brambilla; Maureen M Goodenow; Mostafa Nokta; Suraiya Rasheed; E B Siwak; James Bremer; Diana D Huang; Y Yi; Patricia Reichelderfer; R G Collman
Co-receptor usage was more predictive than NSI/SI phenotype for HIV replication in macrophages: is NSI/SI phenotyping sufficient?
Journal of leukocyte biology 2000;68(3):324-30.
2000: John L Fahey; Najib Aziz; John Spritzler; Susan F Plaeger; P Nishanian; Janet L Lathey; J Seigel; Alan L Landay; R Kilarui; John L Schmitz; C White; Diane Wara; R Akridge; J Cutili; Steven D Douglas; J Reuben; William T Shearer; Mostafa Nokta; R Polland; Robert T Schooley; Deshratn Asthana; Y Mizrachi; M Waxdal
Need for an external proficiency testing program for cytokines, chemokines, and plasma markers of immune activation.
Clinical and diagnostic laboratory immunology 2000;7(4):540-8.
1999: Janet L Lathey; J Tsou; K Brinker; Karen Hsia; William A Meyer; Stephen A Spector
Lack of autologous neutralizing antibody to human immunodeficiency virus type 1 (HIV-1) and macrophage tropism are associated with mother-to-infant transmission.
The Journal of infectious diseases 1999;180(2):344-50.
1998: J Gozlan; Janet L Lathey; Stephen A Spector
Human immunodeficiency virus type 1 induction mediated by genistein is linked to cell cycle arrest in G2.
Journal of virology 1998;72(10):8174-80.
1998: Susan A Fiscus; Michael D Hughes; Janet L Lathey; T Pi; J Brooks Jackson; Suraiya Rasheed; T Elbeik; R Reichman; AJ Japour; R Byington; Walter A Scott; B P Griffith; David A Katzenstein; Scott M Hammer
Changes in virologic markers as predictors of CD4 cell decline and progression of disease in human immunodeficiency virus type 1-infected adults treated with nucleosides. AIDS Clinical Trials Group Protocol 175 Team.
The Journal of infectious diseases 1998;177(3):625-33.
1998: Janet L Lathey; Michael D Hughes; Susan A Fiscus; T Pi; J Brooks Jackson; Suraiya Rasheed; T Elbeik; R Reichman; AJ Japour; Richard T D'Aquila; Walter A Scott; B P Griffith; Scott M Hammer; David A Katzenstein
Variability and prognostic values of virologic and CD4 cell measures in human immunodeficiency virus type 1-infected patients with 200-500 CD4 cells/mm(3) (ACTG 175). AIDS Clinical Trials Group Protocol 175 Team.
The Journal of infectious diseases 1998;177(3):617-24.
1997: N Noraz; Janet L Lathey; Stephen A Spector
Human cytomegalovirus-associated immunosuppression is mediated through interferon-alpha.
Blood 1997;89(7):2443-52.
1997: Janet L Lathey; I C Marschner; B Kabat; Stephen A Spector
Deterioration of detectable human immunodeficiency virus serum p24 antigen in samples stored for batch testing.
Journal of clinical microbiology 1997;35(3):631-5.
1995: P N Gilles; Janet L Lathey; Stephen A Spector
Replication of macrophage-tropic and T-cell-tropic strains of human immunodeficiency virus type 1 is augmented by macrophage-endothelial cell contact.
Journal of virology 1995;69(4):2133-9.
1995: P P Reinhardt; B Reinhardt; Janet L Lathey; Stephen A Spector
Human cord blood mononuclear cells are preferentially infected by non-syncytium-inducing, macrophage-tropic human immunodeficiency virus type 1 isolates.
Journal of clinical microbiology 1995;33(2):292-7.
1995: Susan A Fiscus; Seth Welles; Stephen A Spector; Janet L Lathey
Length of incubation time for human immunodeficiency virus cultures.
Journal of clinical microbiology 1995;33(1):246-7.
1994: Janet L Lathey; Susan A Fiscus; Suraiya Rasheed; J C Kappes; B P Griffith; T Elbeik; Stephen A Spector; Patricia Reichelderfer
Optimization of quantitative culture assay for human immunodeficiency virus from plasma. Plasma Viremia Group Laboratories of the AIDS Clinical Trials Group (National Institute of Allergy and Infectious Diseases).
Journal of clinical microbiology 1994;32(12):3064-7.
1994: Janet L Lathey; S Kanangat; B T Rouse; J M Agosti; Stephen A Spector
Dysregulation of cytokine expression in monocytes from HIV-positive individuals.
Journal of leukocyte biology 1994;56(3):347-52.
1994: Janet L Lathey; Deborah H Spector; Stephen A Spector
Human cytomegalovirus-mediated enhancement of human immunodeficiency virus type-1 production in monocyte-derived macrophages.
Virology 1994;199(1):98-104.
1994: Janet L Lathey; S Kanangat; B T Rouse
Differential expression of tumor necrosis factor alpha and interleukin 1 beta compared with interleukin 6 in monocytes from human immunodeficiency virus-positive individuals measured by polymerase chain reaction.
Journal of acquired immune deficiency syndromes 1994;7(2):109-15.
1993: Stephen A Spector; Karen Hsia; D Pratt; Janet L Lathey; J Allen McCutchan; J E Alcaraz; J Hampton Atkinson; S Gulevich; M Wallace; Igor Grant
Virologic markers of human immunodeficiency virus type 1 in cerebrospinal fluid. The HIV Neurobehavioral Research Center Group.
The Journal of infectious diseases 1993;168(1):68-74.
1992: Janet L Lathey; J M Agosti; S D Spector
A defect in tissue factor expression in monocytes from patients infected by HIV correlates with markers of disease progression.
AIDS (London, England) 1992;6(12):1542-4.
1991: Janet L Lathey; Stephen A Spector
Unrestricted replication of human cytomegalovirus in hydrocortisone-treated macrophages.
Journal of virology 1991;65(11):6371-5.
1990: Janet L Lathey; C A Wiley; M A Verity; Jay A Nelson
Cultured human brain capillary endothelial cells are permissive for infection by human cytomegalovirus.
Virology 1990;176(1):266-73.
1990: Janet L Lathey; J M Agosti; Jay A Nelson; L Corey; S A Gregory; James Morrissey; T S Edgington; M B Oldstone
A selective defect in tissue factor mRNA expression in monocytes from AIDS patients.
Clinical immunology and immunopathology 1990;54(1):1-13.
1988: Janet L Lathey; M B Oldstone
Weight loss in obese mice persistently infected with lymphocytic choriomeningitis virus is not associated with elevated tumor necrosis factor/cachectin activity in peritoneal macrophages.
The American journal of pathology 1988;132(3):586-92.